Abstract 1197: Association of increasing alcohol intake over the lifetime with colorectal adenoma and colorectal cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
Caitlin P. O'Connell, Sonja I. Berndt, Kenechukwu Chudy-Onwugaje, Andrew T. Kunzmann, Wen-Yi Huang, Kathryn Hughes Barry, Erikka Loftfield
{"title":"Abstract 1197: Association of increasing alcohol intake over the lifetime with colorectal adenoma and colorectal cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial","authors":"Caitlin P. O'Connell, Sonja I. Berndt, Kenechukwu Chudy-Onwugaje, Andrew T. Kunzmann, Wen-Yi Huang, Kathryn Hughes Barry, Erikka Loftfield","doi":"10.1158/1538-7445.am2025-1197","DOIUrl":null,"url":null,"abstract":"Introduction: Recent alcohol drinking has been associated with higher colorectal cancer (CRC) risk. However, research on lifetime alcohol drinking in relation to colorectal adenoma (CRC precursor) and CRC risk is limited. We aimed to estimate the association of average lifetime alcohol drinking and change in alcohol consumption over adulthood with incident colorectal adenoma and cancer. Methods: U.S. adults enrolled in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial were asked about alcohol intake during four age periods (18-24, 25-39, 40-54, and ≥55 years) as part of a dietary history questionnaire (DHQ). Participants were also asked about alcohol consumption in the year prior to the DHQ (reflecting current drinking). Average lifetime alcohol intake was calculated as average drinks per week from early adulthood (age 18-24) until age at DHQ completion (median of 65 years). Change in alcohol intake was defined as the difference between alcohol intake at the DHQ and age 18-24. Incident adenomas (n=807, including 196 advanced adenomas) were defined in the screening arm based on a negative baseline trial screen and a positive follow-up trial screen 3 or 5 years later; controls (n=11, 446) were defined based on negative baseline and follow-up screens. CRC incidence (n=1, 679) was defined based on 20 years of cancer follow-up in both trial arms. Multivariable-adjusted logistic regression models were used to estimate odds ratios (OR) and 95% confidence intervals (CI) for incident adenoma. Multivariable-adjusted Cox proportional hazard regression models were used to estimate hazard ratios (HR) and 95% CI for CRC. Models adjusted for a number of potential confounders including demographic factors, body mass index, family history of CRC, and various dietary factors. P-values for interaction between alcohol intake and sex were computed using likelihood ratio tests comparing models with and without the interaction terms. Results: Increasing alcohol intake by 1 drink/day every 10 years was associated with higher risk of adenoma (OR=1.19, CI: 1.02-1.39), advanced adenoma (OR=1.41, CI: 1.11-1.79), and CRC (HR=1.11, CI: 0.99-1.24). Among men, drinking ≥14 drinks/week, compared to <1 drink/week, throughout adulthood was positively associated with risk of advanced adenoma (OR=1.83, CI: 0.95-3.50) as well as rectal (HR=1.80, CI: 1.03-3.13) and distal colon (HR=1.54, CI: 0.98-2.42) but not proximal colon (HR=0.96, CI: 0.71-1.31) cancer. Associations tended to be less pronounced among women, but with limited case numbers, we found no evidence of significant effect modification by sex (p-interaction>0.05). Conclusions: Our study suggests that increasing alcohol intake over the lifetime and higher average lifetime alcohol drinking is associated with a higher risk of advanced colorectal adenoma and CRC. Citation Format: Caitlin P. O'Connell, Sonja I. Berndt, Kenechukwu Chudy-Onwugaje, Andrew T. Kunzmann, Wen-Yi Huang, Kathryn Hughes Barry, Erikka Loftfield. Association of increasing alcohol intake over the lifetime with colorectal adenoma and colorectal cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 1 (Regular s); 2025 Apr 25-30; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1): nr 1197.","PeriodicalId":9441,"journal":{"name":"Cancer research","volume":"17 1","pages":""},"PeriodicalIF":12.5000,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1158/1538-7445.am2025-1197","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Recent alcohol drinking has been associated with higher colorectal cancer (CRC) risk. However, research on lifetime alcohol drinking in relation to colorectal adenoma (CRC precursor) and CRC risk is limited. We aimed to estimate the association of average lifetime alcohol drinking and change in alcohol consumption over adulthood with incident colorectal adenoma and cancer. Methods: U.S. adults enrolled in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial were asked about alcohol intake during four age periods (18-24, 25-39, 40-54, and ≥55 years) as part of a dietary history questionnaire (DHQ). Participants were also asked about alcohol consumption in the year prior to the DHQ (reflecting current drinking). Average lifetime alcohol intake was calculated as average drinks per week from early adulthood (age 18-24) until age at DHQ completion (median of 65 years). Change in alcohol intake was defined as the difference between alcohol intake at the DHQ and age 18-24. Incident adenomas (n=807, including 196 advanced adenomas) were defined in the screening arm based on a negative baseline trial screen and a positive follow-up trial screen 3 or 5 years later; controls (n=11, 446) were defined based on negative baseline and follow-up screens. CRC incidence (n=1, 679) was defined based on 20 years of cancer follow-up in both trial arms. Multivariable-adjusted logistic regression models were used to estimate odds ratios (OR) and 95% confidence intervals (CI) for incident adenoma. Multivariable-adjusted Cox proportional hazard regression models were used to estimate hazard ratios (HR) and 95% CI for CRC. Models adjusted for a number of potential confounders including demographic factors, body mass index, family history of CRC, and various dietary factors. P-values for interaction between alcohol intake and sex were computed using likelihood ratio tests comparing models with and without the interaction terms. Results: Increasing alcohol intake by 1 drink/day every 10 years was associated with higher risk of adenoma (OR=1.19, CI: 1.02-1.39), advanced adenoma (OR=1.41, CI: 1.11-1.79), and CRC (HR=1.11, CI: 0.99-1.24). Among men, drinking ≥14 drinks/week, compared to <1 drink/week, throughout adulthood was positively associated with risk of advanced adenoma (OR=1.83, CI: 0.95-3.50) as well as rectal (HR=1.80, CI: 1.03-3.13) and distal colon (HR=1.54, CI: 0.98-2.42) but not proximal colon (HR=0.96, CI: 0.71-1.31) cancer. Associations tended to be less pronounced among women, but with limited case numbers, we found no evidence of significant effect modification by sex (p-interaction>0.05). Conclusions: Our study suggests that increasing alcohol intake over the lifetime and higher average lifetime alcohol drinking is associated with a higher risk of advanced colorectal adenoma and CRC. Citation Format: Caitlin P. O'Connell, Sonja I. Berndt, Kenechukwu Chudy-Onwugaje, Andrew T. Kunzmann, Wen-Yi Huang, Kathryn Hughes Barry, Erikka Loftfield. Association of increasing alcohol intake over the lifetime with colorectal adenoma and colorectal cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 1 (Regular s); 2025 Apr 25-30; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1): nr 1197.
期刊介绍:
Cancer Research, published by the American Association for Cancer Research (AACR), is a journal that focuses on impactful original studies, reviews, and opinion pieces relevant to the broad cancer research community. Manuscripts that present conceptual or technological advances leading to insights into cancer biology are particularly sought after. The journal also places emphasis on convergence science, which involves bridging multiple distinct areas of cancer research.
With primary subsections including Cancer Biology, Cancer Immunology, Cancer Metabolism and Molecular Mechanisms, Translational Cancer Biology, Cancer Landscapes, and Convergence Science, Cancer Research has a comprehensive scope. It is published twice a month and has one volume per year, with a print ISSN of 0008-5472 and an online ISSN of 1538-7445.
Cancer Research is abstracted and/or indexed in various databases and platforms, including BIOSIS Previews (R) Database, MEDLINE, Current Contents/Life Sciences, Current Contents/Clinical Medicine, Science Citation Index, Scopus, and Web of Science.